November 19, 2010 — Heel USA, the makers of Traumeel, a top seller for pain management and sports injuries, announced that clinically researched1 Engystol is expecting to double in sales by the end of the year as doctors and consumers alike prepare for the flu season.
Popularity continues to grow for this safe, doctor-recommended natural medicine formulated to support the immune system and provide relief of the symptoms of flu such as fever, body aches, and chills.
Since being introduced to retailers nationwide sales have been robust according to CEO, Thierry Montfort; “Part of the reason for its growth is consumers are both health conscious and, with this tough economy, they are penny-wise too.”
Recent news2 on consumer cost cutting strategies reveal more of us are purchasing value packs and stocking up while shopping close to home. Engystol is a value purchase for the entire family even infants. There is no need to purchase multiple products per age group or specific symptom.
When making a decision to stock the medicine cabinet with either chemically formulated medicine or natural products, Engystol is a safe and effective choice.
Engystol is regulated by the FDA as a homeopathic medicine. Engystol works to stimulate the immune system to help the body feel better from the symptoms of the flu. Parents can safely give Engystol to their children as young as infants.
This is a relief for parents especially with the recent news of the FDA hearings on taking dozens of OTC cold and cough products to prescription only3. The decision was made to keep medicines available on the shelf citing that the benefits outweigh the risks.
Source: Heel USA, www.heelusa.com
References
2http://blog.nielsen.com/nielsenwire/consumer/global-consumer-strategies-for-saving-money/
Related Posts
Foot Levelers announces Federation Internationale de Chiropratique du Sport Scholarship- The ‘vital’ wellness check: good for your patients and your practice
- Parker College of Chiropractic transitions to new name, university status
- Standard Process Inc. earns ‘Distinguished Performer Award’
- Florida looks to approve hemp plan; FDA holding public CBD hearing this week
